Matches in Wikidata for { <http://www.wikidata.org/entity/Q60960762> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- Q60960762 description "article scientifique publié en 2019" @default.
- Q60960762 description "wetenschappelijk artikel" @default.
- Q60960762 description "наукова стаття, опублікована в січні 2019" @default.
- Q60960762 name "Efficacy and Safety of Lipase Inhibitor Orlistat in Japanese with Excessive Visceral Fat Accumulation: 24-Week, Double-Blind, Randomized, Placebo-Controlled Study" @default.
- Q60960762 name "Efficacy and Safety of Lipase Inhibitor Orlistat in Japanese with Excessive Visceral Fat Accumulation: 24-Week, Double-Blind, Randomized, Placebo-Controlled Study" @default.
- Q60960762 type Item @default.
- Q60960762 label "Efficacy and Safety of Lipase Inhibitor Orlistat in Japanese with Excessive Visceral Fat Accumulation: 24-Week, Double-Blind, Randomized, Placebo-Controlled Study" @default.
- Q60960762 label "Efficacy and Safety of Lipase Inhibitor Orlistat in Japanese with Excessive Visceral Fat Accumulation: 24-Week, Double-Blind, Randomized, Placebo-Controlled Study" @default.
- Q60960762 prefLabel "Efficacy and Safety of Lipase Inhibitor Orlistat in Japanese with Excessive Visceral Fat Accumulation: 24-Week, Double-Blind, Randomized, Placebo-Controlled Study" @default.
- Q60960762 prefLabel "Efficacy and Safety of Lipase Inhibitor Orlistat in Japanese with Excessive Visceral Fat Accumulation: 24-Week, Double-Blind, Randomized, Placebo-Controlled Study" @default.
- Q60960762 P1433 Q60960762-DAC39ACB-E1F9-47BC-B29E-31272576F1EF @default.
- Q60960762 P1476 Q60960762-EE2A0F6F-25FC-4EE3-BAD1-012493ED7A41 @default.
- Q60960762 P2093 Q60960762-09297C58-511D-44AC-9242-8E34D6CBFDC4 @default.
- Q60960762 P2093 Q60960762-40ADF01A-8DD9-4A71-8358-A2990C2A4E84 @default.
- Q60960762 P2093 Q60960762-53F5B7A1-D44E-4D78-9A2B-16F3B2E6300D @default.
- Q60960762 P2093 Q60960762-BFEF1583-2676-4076-BB69-81BAF4F9A781 @default.
- Q60960762 P2093 Q60960762-C28C8B8F-0E7A-4A79-ACEE-8720B7EE44A9 @default.
- Q60960762 P2093 Q60960762-EC96CD69-DF65-4497-81A7-5FA7514EE666 @default.
- Q60960762 P2093 Q60960762-EDD96872-0FBE-4C9A-B581-B95796C0ED48 @default.
- Q60960762 P2860 Q60960762-146CC005-9DDD-497B-A246-18EEDB6804E1 @default.
- Q60960762 P2860 Q60960762-15269745-7CC1-45D2-9150-52C24CFA7BB7 @default.
- Q60960762 P2860 Q60960762-37B2B8BC-2A1F-4B0D-8CDA-10E4A593CEF7 @default.
- Q60960762 P2860 Q60960762-45697323-969F-4813-BF34-D1D947084C8F @default.
- Q60960762 P2860 Q60960762-840531F8-AA01-4551-A339-C8ABE39CE231 @default.
- Q60960762 P2860 Q60960762-8B1EBA32-4544-4DC1-961E-E5A9DC7635CB @default.
- Q60960762 P2860 Q60960762-A09673C5-68AF-46C6-823B-2E6BC0E906CA @default.
- Q60960762 P2860 Q60960762-ACFD9388-8CE0-4D39-B51E-1E650C0845D5 @default.
- Q60960762 P2860 Q60960762-C77CA767-D04E-4020-A67F-9BD2A0ECA111 @default.
- Q60960762 P2860 Q60960762-FE15B98F-529C-408F-8385-6D3C425672AA @default.
- Q60960762 P2888 Q60960762-EF838EAD-A3D3-4EE1-8788-83FF733878DF @default.
- Q60960762 P304 Q60960762-E956E254-B75E-4652-82F5-B181A72075D9 @default.
- Q60960762 P31 Q60960762-95952AF2-8E1E-49BF-875D-6C8BAE270DC9 @default.
- Q60960762 P356 Q60960762-1421BFD1-2530-44E6-9141-497F31495C36 @default.
- Q60960762 P407 Q60960762-40FFF9E9-3D8B-483D-9E89-4B8319A6045D @default.
- Q60960762 P433 Q60960762-F2BE2D18-47B4-4560-9F04-23E307FECD02 @default.
- Q60960762 P478 Q60960762-C154E84E-E98C-4572-BBF2-3A684185E7ED @default.
- Q60960762 P577 Q60960762-6E3E8C20-8664-40E0-9C95-7AE20A04A14B @default.
- Q60960762 P698 Q60960762-30312273-1D0D-4C5A-950B-17ACBF487258 @default.
- Q60960762 P921 Q60960762-4DF760DC-752A-466A-9BF9-DC20DCE93E81 @default.
- Q60960762 P921 Q60960762-64D162FD-D20C-4579-A3E9-90D1C3822238 @default.
- Q60960762 P932 Q60960762-E62762BB-7234-40E6-B3BD-78D73037178A @default.
- Q60960762 P356 S12325-018-0835-5 @default.
- Q60960762 P698 30535651 @default.
- Q60960762 P1433 Q4686392 @default.
- Q60960762 P1476 "Efficacy and Safety of Lipase Inhibitor Orlistat in Japanese with Excessive Visceral Fat Accumulation: 24-Week, Double-Blind, Randomized, Placebo-Controlled Study" @default.
- Q60960762 P2093 "Kohji Shirai" @default.
- Q60960762 P2093 "Masatsugu Shimomasuda" @default.
- Q60960762 P2093 "Michitaka Tanaka" @default.
- Q60960762 P2093 "Soichi Sakai" @default.
- Q60960762 P2093 "Toru Fujita" @default.
- Q60960762 P2093 "Yoshishige Samukawa" @default.
- Q60960762 P2093 "Yuka Fujii" @default.
- Q60960762 P2860 Q28288766 @default.
- Q60960762 P2860 Q34303796 @default.
- Q60960762 P2860 Q37151277 @default.
- Q60960762 P2860 Q42221296 @default.
- Q60960762 P2860 Q47433867 @default.
- Q60960762 P2860 Q53216225 @default.
- Q60960762 P2860 Q73490701 @default.
- Q60960762 P2860 Q80466088 @default.
- Q60960762 P2860 Q85235544 @default.
- Q60960762 P2860 Q87811000 @default.
- Q60960762 P2888 s12325-018-0835-5 @default.
- Q60960762 P304 "86-100" @default.
- Q60960762 P31 Q13442814 @default.
- Q60960762 P356 "10.1007/S12325-018-0835-5" @default.
- Q60960762 P407 Q1860 @default.
- Q60960762 P433 "1" @default.
- Q60960762 P478 "36" @default.
- Q60960762 P577 "2019-01-01T00:00:00Z" @default.
- Q60960762 P698 "30535651" @default.
- Q60960762 P921 Q269829 @default.
- Q60960762 P921 Q6556253 @default.
- Q60960762 P932 "6318260" @default.